Clinical Trial Update: BLOC-ICH: Interleukin-1 Receptor Antagonist in Intracerebral Haemorrhage [Phase 2]

View source ↗

Summary

Phase 2 trial update for an interleukin-1 receptor antagonist (BLOC-ICH) in intracerebral haemorrhage is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracerebral Haemorrhage

Drugs mentioned

• Interleukin-1 Receptor Antagonist (Interleukin-1 receptor antagonist)

Snippet

Sponsor: Adrian Parry-Jones | Conditions: Intracerebral Haemorrhage | Phase 2 | Status: COMPLETED